Gastroparesis

• FDA label_change · 2021-01-14
  FDA Approved: GIMOTI — Supplemental Application (Evoke Pharma, Inc.)

  FDA approved a supplemental application for GIMOTI (metoclopramide hydrochloride) submitted by Evoke Pharma, resulting in labeling changes f…

• FDA label_change · 2017-08-29
  FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for REGLAN (metoclopramide hydrochloride) from ANI Pharmaceuticals, Inc., resulting in changes t…

• FDA label_change · 2014-12-10
  FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for metoclopramide submitted by Teva Pharmaceuticals USA, Inc. to modify the drug labeling.

• FDA label_change · 2011-02-28
  FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved Teva's supplemental application for metoclopramide, resulting in changes to the drug's labeling.

• FDA label_change · 2007-01-24
  FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., resulting in changes to the product labe…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.